Esoreg-D Capsule SR is a combination medication containing Domperidone 30mg and Esomeprazole 40mg, designed to provide effective relief from gastrointestinal disorders. Domperidone is a prokinetic agent that enhances gastric motility by blocking dopamine receptors, thereby facilitating faster gastric emptying and reducing symptoms such as nausea, vomiting, and bloating. Esomeprazole, a proton pump inhibitor (PPI), works by suppressing gastric acid secretion through irreversible inhibition of the H+/K+ ATPase enzyme system in the stomach lining, providing relief from acid-related conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. The sustained-release formulation of Esoreg-D ensures prolonged therapeutic action, improving patient compliance by reducing dosing frequency. This combination is particularly beneficial for patients experiencing acid reflux accompanied by delayed gastric emptying or motility issues. It is generally well-tolerated, but patients should use it under medical supervision, especially those with liver impairment, cardiac conditions, or those taking other medications that may interact with Domperidone or Esomeprazole. Esoreg-D Capsule SR offers a comprehensive approach to managing upper gastrointestinal symptoms by addressing both acid suppression and motility enhancement, thereby improving overall digestive comfort and quality of life.